JPM
JPMorgan Chase & Co.
JPM has the edge over MBWM overall, supported by stronger modeled upside and lower modeled downside.
MBWM
Mercantile Bank Corporation
MBWM trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MBWM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MBWM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBWM.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over MBWM in the historical PE scenario, which offers more potential upside but is not a forecast.
MBWM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $41.04 | -33% |
| Fair | 9.2x | $51.59 | -16% |
| Expensive | 11x | $59.31 | -2.9% |
| Current | 11x | $61.11 | — |
| Forward | 11x | $61.11 | — |
Historical ranges are pointers, not guarantees.
MBWM's PE is in its expensive range at 10.9x. On analysts' estimates for next year's earnings, today's price would be 10.7x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over MBWM on the outlook, with more favorable profitability expectations.
MBWM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MBWM, but weaker profitability.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MBWM on earnings, with more consistent year-over-year improvement.
MBWM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.72 | +1.7% |
| Q3 2026 | $5.62 | +6.8% |
| Q2 2026 | $5.69 | +13% |
| Q1 2026 | $5.58 | +16% |
| Q4 2025 | $5.47 | +11% |
| Q3 2025 | $5.26 | +5.6% |
| Q2 2025 | $5.02 | -0.8% |
| Q1 2025 | $4.80 | -7% |
| Q4 2024 | $4.93 | -3.9% |
MBWM earned $5.62 per share over the past year, up 6.8% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over MBWM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MBWM on profitability, with a higher operating margin.
MBWM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $73.2M | +17% |
| Q2 2026 | $68.8M | +13% |
| Q1 2026 | $67.6M | +18% |
| Q4 2025 | $62.1M | +6% |
| Q3 2025 | $62.4M | +7.6% |
| Q2 2025 | $60.9M | +7.4% |
| Q1 2025 | $57.3M | -1.7% |
| Q4 2024 | $58.5M | +2.8% |
MBWM's revenue has grown year over year for six quarters in a row: $73M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -4.4 points |
| Q2 2026 | 45% | +2.8 points |
| Q1 2026 | 40% | -1.6 points |
| Q4 2025 | 42% | +2.3 points |
| Q3 2025 | 44% | +1.6 points |
| Q2 2025 | 43% | +1.2 points |
| Q1 2025 | 42% | -4.3 points |
| Q4 2024 | 40% | -4.6 points |
MBWM's operating margin was 40% last quarter, down 4.4 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MBWM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.1M | +104% |
| Q2 2026 | $15.3M | +$23.1M |
| Q1 2026 | $28.3M | +$31.3M |
| Q4 2025 | $5.6M | -91% |
| Q3 2025 | $23.1M | +$31.2M |
| Q2 2025 | -$7.8M | -186% |
| Q1 2025 | -$3M | -107% |
| Q4 2024 | $59.9M | +$67.2M |
MBWM has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MBWM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MBWM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | +6.4% | +1M shares |
| 3 years | +7.9% | +1.3M shares |
| 5 years | +9% | +1.4M shares |
| Available history | +5.3% | +877K shares |
MBWM has 17M diluted shares, up 6.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1.6M |
| Q3 2021 | $8.9M |
| Q2 2021 | $7.3M |
| Q1 2021 | $3.5M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MBWM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
MBWM has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MBWM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.0 | Neutral |
| Stochastic | 55.7 | Neutral |
MBWM's weekly RSI is 60 (neutral) and its Stochastic is 56 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MBWM PE vs Financial Services Sector
| Metric | MBWM | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 87 | 63 | 24 pts above |
MBWM has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
MBWM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.8 | 2.2% above |
| 20 week MA | $59.8 | 2.2% above |
| 50 week MA | $54.8 | 12% above |
| 100 week MA | $50.1 | 22% above |
| 200 week MA | $43.5 | 41% above |
MBWM has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
MBWM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.7 | $27.2 | -26% |
| 2021 | $27.2 | $35.1 | +29% |
| 2022 | $35.1 | $33.8 | -3.7% |
| 2023 | $33.8 | $40.4 | +20% |
| 2024 | $40.4 | $44.8 | +11% |
| 2025 | $44.8 | $48.7 | +8.8% |
| 2026 YTD | $48.7 | $61.1 | +25% |
MBWM has the edge over JPM on returns for 2026, with the stronger performance.